1282P Trial-based costs of all-cause adverse events in first-line therapy for advanced non-small cell lung cancer: Findings from CheckMate-227D. Stenehjem,S.J. Lubinga,S.B. King,K.A. Betts,S. Rao,F. Castriota, M. Mahin, E. Orvis, S. Marathe,J. MaAnnals of Oncology（2020）引用 0|浏览19暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
